The abstract is read at the publisher; the summary is JClub's.
Light-sheet imaging in zebrafish larvae identifies an optimal 30–90 min post-injection window for ranking five tumor-targeting aptamers, including one negative control oligonucleotide.
- Why it matters: In vitro aptamer screening is established, but systematic quantitative in vivo ranking is constrained by time and cost of rodent models.
- What they did: Aptamers were systemically administered to zebrafish larvae in a neuroblastoma model, then imaged and detected with qPCR to define the 30–90 min screening window.
- The result: Zebrafish larvae ranking differed from in vitro screening across neuroblastoma cell lines, and the lead aptamer on fusogenic nanovesicles accumulated in neuroblastoma-preferentially 1–2 h post-injection.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.